The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.